Compounds > 5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone
Page last updated: 2024-09-04

5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone and Glioma

5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone has been researched along with Glioma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hjelmeland, AB; King, PH; Nabors, LB; Wang, J1

Other Studies

1 other study(ies) available for 5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone and Glioma

ArticleYear
Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.
    Cancer biology & therapy, 2019, Volume: 20, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; ELAV-Like Protein 1; Furans; Gene Expression Regulation, Neoplastic; Glioma; Humans; Naphthols; RNA Stability

2019